FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1828-1834 December 17, 1998 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Primary aldosteronism resulting from an adrenocortical adenoma (aldosteronoma), as described by Conn,¹ is one of a few potentially curable forms of hypertension. Aldosteronoma is the most common cause of primary aldosteronism. Aldosteronomas are usually small (less than 2 cm in diameter), are benign, and have a golden yellow color on their cut surfaces (Figure 1), with different adrenal-cell types visible on microscopy. Idiopathic aldosteronism, which is associated with bilateral micronodular or macronodular adrenal hyperplasia, constitutes 20 to 30 percent of cases of primary aldosteronism,^{2,3,4,5,6,7,8} although it is considered by some to be a variant of essential hypertension.⁹ Unilateral . . . [Full Text of this Article]

Pathophysiologic Changes in Aldosterone Secretion

Prevalence

Clinical Characteristics

Biochemical Findings

Screening

Diagnosis

Differential Diagnosis

Treatment

Source Information

From the Medical Service, James A. Haley Veterans Affairs Hospital and University of South Florida College of Medicine, Tampa.

Address reprint requests to Dr. Ganguly at the Veterans Affairs Hospital 111-M, 13000 Bruce B. Downs Blvd., Tampa, FL 33612.

References

This article has been cited by other articles:

• Kjeldsen, S. E., Aksnes, T. A., Fagard, R. H., Mancia, G. (2009). CHAPTER 13 Hypertension. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Jeon, J. H., Kim, K.-y., Kim, J. H., Baek, A., Cho, H., Lee, Y. H., Kim, J. W., Kim, D., Han, S. H., Lim, J.-S., Kim, K. I., Yoon, D. Y., Kim, S.-H., Oh, G. T., Kim, E., Yang, Y. (2008). A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 22: 1502-1511 [Abstract] [Full Text]  
• Umpierrez, G. E., Cantey, P., Smiley, D., Palacio, A., Temponi, D., Luster, K., Chapman, A. (2007). Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension. Diabetes Care 30: 1699-1703 [Abstract] [Full Text]  
• Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full Text]  
• Bubbar, C. D, Blackburn, D. F, Wilson, M. P, Wilson, T. W (2007). Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension Due to Primary Aldosteronism: A Case for Exclusion. The Annals of Pharmacotherapy 41: 129-132 [Abstract] [Full Text]  
• Nwariaku, F. E., Miller, B. S., Auchus, R., Holt, S., Watumull, L., Dolmatch, B., Nesbitt, S., Vongpatanasin, W., Victor, R., Wians, F., Livingston, E., Snyder, W. H. III (2006). Primary Hyperaldosteronism: Effect of Adrenal Vein Sampling on Surgical Outcome. Arch Surg 141: 497-503 [Abstract] [Full Text]  
• Shigematsu, K., Kawai, K., Irie, J., Sakai, H., Nakashima, O., Iguchi, A., Shimamatsu, J., Shimamatsu, K., Kusaba, Y., Takahara, O. (2006). Analysis of Unilateral Adrenal Hyperplasia with Primary Aldosteronism from the Aspect of Messenger Ribonucleic Acid Expression for Steroidogenic Enzymes: A Comparative Study with Adrenal Cortices Adhering to Aldosterone-Producing Adenoma. Endocrinology 147: 999-1006 [Abstract] [Full Text]  
• Wu, H.-H., Chang, C.-T., Yen, T.-H., Hung, C.-C. (2005). A case of adrenal aldosteronoma with horseshoe kidney and duplicated inferior vena cava. Nephrol Dial Transplant 20: 2858-2860 [Full Text]  
• Seccia, T. M, Fassina, A., Nussdorfer, G. G, Pessina, A. C, Rossi, G. P. (2005). Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer 12: 149-159 [Abstract] [Full Text]  
• Tiu, S.-C., Choi, C.-H., Shek, C.-C., Ng, Y.-W., Chan, F. K. W., Ng, C.-M., Kong, A. P. S. (2005). The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling. J. Clin. Endocrinol. Metab. 90: 72-78 [Abstract] [Full Text]  
• Karagiannis, A., Tziomalos, K., Kakafika, A., Harsoulis, F., Zamboulis, C. (2004). Paralysis as first manifestation of primary aldosteronism. Nephrol Dial Transplant 19: 2418-2419 [Full Text]  
• Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W.F., Meigs, J. B., Rifai, N., Benjamin, E. J., Levy, D. (2004). Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons. NEJM 351: 33-41 [Abstract] [Full Text]  
• Plouin, P.-F., Amar, L., Chatellier, G. (2004). Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant 19: 774-777 [Full Text]  
• Caliumi, C., De Toma, G., Bossini, A., Cianci, R., Bosman, C., Genuardi, M., Cerci, S., Letizia, C. (2004). A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma (RB) gene. Journal of Renin-Angiotensin-Aldosterone System 5: 45-48 [Abstract]  
• Mulatero, P., Stowasser, M., Loh, K.-C., Fardella, C. E., Gordon, R. D., Mosso, L., Gomez-Sanchez, C. E., Veglio, F., Young, W. F. Jr. (2004). Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents. J. Clin. Endocrinol. Metab. 89: 1045-1050 [Abstract] [Full Text]  
• Mosso, L., Carvajal, C., Gonzalez, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A., Fardella, C. E. (2003). Primary Aldosteronism and Hypertensive Disease. Hypertension 42: 161-165 [Abstract] [Full Text]  
• Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., Veglio, F. (2002). Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism. Hypertension 40: 897-902 [Abstract] [Full Text]  
• Oliveira, G. H. M., Garovic, V. D. (2002). 23-Year-Old Man With Hypertension and Flank Trauma. Mayo Clin Proc. 77: 1229-1232  
• Castro, O. L., Yu, X., Kem, D. C. (2002). Diagnostic Value of the Post-Captopril Test in Primary Aldosteronism. Hypertension 39: 935-938 [Abstract] [Full Text]  
• Stowasser, M., Gordon, R. D, Rutherford, J. C, Nikwan, N. Z, Daunt, N., Slater, G. J (2001). Review: Diagnosis and management of primary aldosteronism. Journal of Renin-Angiotensin-Aldosterone System 2: 156-169  
• Agharazii, M., Douville, P., Grose, J. H., Lebel, M. (2001). Captopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism. Hypertension 37: 1440-1443 [Abstract] [Full Text]  
• Magill, S. B., Raff, H., Shaker, J. L., Brickner, R. C., Knechtges, T. E., Kehoe, M. E., Findling, J. W. (2001). Comparison of Adrenal Vein Sampling and Computed Tomography in the Differentiation of Primary Aldosteronism. J. Clin. Endocrinol. Metab. 86: 1066-1071 [Abstract] [Full Text]  
• Rossi, G. P., Sacchetto, A., Chiesura-Corona, M., De Toni, R., Gallina, M., Feltrin, G. P., Pessina, A. C. (2001). Identification of the Etiology of Primary Aldosteronism with Adrenal Vein Sampling in Patients with Equivocal Computed Tomography and Magnetic Resonance Findings: Results in 104 Consecutive Cases. J. Clin. Endocrinol. Metab. 86: 1083-1090 [Abstract] [Full Text]  
• Phillips, J. L., Walther, M. M., Pezzullo, J. C., Rayford, W., Choyke, P. L., Berman, A. A., Linehan, W. M., Doppman, J. L., Gill, J. R. Jr. (2000). Predictive Value of Preoperative Tests in Discriminating Bilateral Adrenal Hyperplasia from an Aldosterone-Producing Adrenal Adenoma. J. Clin. Endocrinol. Metab. 85: 4526-4533 [Abstract] [Full Text]  
• Oelkers, W., Diederich, S., Bähr, V. (2000). Primary Hyperaldosteronism without Suppressed Renin Due to Secondary Hypertensive Kidney Damage. J. Clin. Endocrinol. Metab. 85: 3266-3270 [Abstract] [Full Text]  
• Stowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R., Gordon, R. D. (2000). Treatment of Familial Hyperaldosteronism Type I: Only Partial Suppression of Adrenocorticotropin Required to Correct Hypertension. J. Clin. Endocrinol. Metab. 85: 3313-3318 [Abstract] [Full Text]  
• Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., Montero, J. (2000). Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology. J. Clin. Endocrinol. Metab. 85: 1863-1867 [Abstract] [Full Text]  
• Mulatero, P., Schiavone, D., Fallo, F., Rabbia, F., Pilon, C., Chiandussi, L., Pascoe, L., Veglio, F. (2000). CYP11B2 Gene Polymorphisms in Idiopathic Hyperaldosteronism. Hypertension 35: 694-698 [Abstract] [Full Text]